Stock performance and business mix snapshot
CNO Financial Group (CNO) has attracted fresh attention as investors reassess U.S. insurers, with the stock recently closing at $41.16 and showing mixed returns over the past week, month, and past 3 months.
The company focuses on middle income pre retiree and retired Americans, generating US$4,487.4 million in revenue and US$229.3 million in net income, with modest reported annual revenue growth and stronger net income growth.
See our latest analysis for CNO Financial Group.
CNO’s recent share price returns have been mixed, with a modest 7 day gain set against weaker 3 month and year to date share price returns. However, multi year total shareholder returns above 80% suggest longer term investors have still been rewarded.
If you are weighing CNO against other opportunities in financials, it can help to see how founder run or founder backed businesses have performed. Now is a good time to broaden your search with the 20 top founder-led companies
With CNO trading at $41.16, sitting below a US$47 analyst price target and at an estimated intrinsic discount of about 43%, you have to ask: is this a genuine value opportunity, or is the market already reflecting future growth?
Most Popular Narrative: 12.4% Undervalued
At $41.16, the most followed narrative points to a fair value of $47, suggesting the model sees more upside than the current share price reflects.
Accelerating growth in annuity and life/health policy sales, particularly driven by a rapidly aging U.S. population (11,000 Americans turning 65 each day) and increased focus on retirement income solutions, is expanding CNO's addressable market and supporting consistent, repeatable revenue gains.
Curious what kind of earnings expansion and margin profile sits behind that view, and how it ties into a lower future P/E and ongoing buybacks? The full narrative connects these moving parts, step by step, into one valuation story.
Result: Fair Value of $47 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, this story can change quickly if long term interest rates stay low or long term care claims rise, as both could pressure margins and earnings.
Find out about the key risks to this CNO Financial Group narrative.
Another View: Market Multiple Sends a Different Signal
While the narrative points to CNO as undervalued by about 43% versus an internal fair value estimate, the current 16.8x P/E sits well above the US Insurance industry at 11.4x and a fair ratio of 14.5x. That premium hints at less room for error than the discount headline suggests. The question is which signal you trust more.
See what the numbers say about this price — find out in our valuation breakdown.
Next Steps
Mixed signals on value and risk so far. If this has you on the fence, this may be an appropriate time to review the 3 key rewards and 4 important warning signs
Looking for more investment ideas?
If CNO has your attention, do not stop here. Use this momentum to scan for other opportunities that match your style before the next move passes by.
- Target quality at a discount by reviewing companies highlighted in the 58 high quality undervalued stocks and see which ones deserve a closer look.
- Prioritise resilience by checking out the 68 resilient stocks with low risk scores and focus on businesses that aim to keep risk scores in check.
- Spot under the radar opportunities by running the screener containing 25 high quality undiscovered gems and see which strong fundamentals the market may be overlooking.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com